Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by thediggeron Nov 30, 2018 11:32am

64 Views

Post# 29045417

RE:RE:RE:RE:RE:RE:RE:New Age needs to

Ok, I may have misread it somewhere. But hemp has still high CBD content. For the Walmart thing, I don't know but it is very possible. CBD water was temporarily in Target before being removed, in 2017 if I recall. It may easily come back once hemp is legalized, who knows.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?